Business and management consultancy and related services

Tender description

Universities are rising to the challenge of commercialisation inventions, research, innovations, discovery and intellectual property. This is done through a variety of methods and funding sources which are made available to Universities. One of which is the Northern Accelerator brand. PulmoBiomed Technology Breath analysis opens up a new non-invasive source of diagnostic data. Solving the challenges of creating a diagnostic platform based on breath will generate a raft of patient-centred solutions, products and commercial opportunities. The initial brief of the executive will be to: 1) Produce a viable business plan; 2) Obtain university approval for the venture; 3a) Act for the company in the spin-out legal process and address all company formation matters; 3b) Obtain founder academics’ and Northumbria University (including the Director of Research and Innovation) approval for appointment as CEO. 3c) Provide to the appropriate university all matters necessary for ERDF/Research England reporting requirements; 4) Secure (venture capital and/or other) funding in accordance with the business plan. Newcastle, Durham, Sunderland and Northumbria universities, in common with universities throughout the UK, have advanced relevant systems and procedures and also dedicate significant public resource to both research and commercialisation of that research. A key route to commercialisation is the creation of a new business (a spin-out company) wherein the intellectual property (IPR) developed exclusively licenced to a university start-up company in exchange for (founders) shares in that company. The universities ill engage suitably qualified and experienced executives through the DPS as and when required over the DPS period. The specific requirements will be detailed in each further competition. The initial brief of the executive for which he/she will be paid, dependent upon the scope of the specific project engagement sought, either a payment or a combination of a payment and a share/stock option will typically be to: (a) produce a viable business plan; (b) obtain university approval for the venture (c) act for the company in the spin-out legal process and address all the company formation matters; (d) provide to the appropriate university all matters necessary for ERDF, ESIF and Research England reporting requirements; (e) secure (venture capital and/or other) funding in accordance with the business plan.